The incidence of metamizole sodium-induced agranulocytosis in Poland

Journal of International Medical Research

Volumn 30, Issue 5, 2002, Pages 488-495

  Maj, S ^a   Lis, Y ^b  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^b Carter Lis Associates Ltd   (United Kingdom)

Author keywords

Agranulocytosis; Analgesic; Incidence; Metamizole sodium; Poland

Indexed keywords

DIPYRONE; NONSTEROID ANTIINFLAMMATORY AGENT; ACETYLSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; ANALGESIC AGENT; ANTITHYROID AGENT; ASCORBIC ACID; CAPTOPRIL; CYPROTERONE; DEXTROMORAMIDE; DICLOFENAC; DOXYCYCLINE; GLICLAZIDE; INDOMETACIN; METHOTREXATE; NABUMETONE; PARACETAMOL; PENICILLIN G; PROCAINAMIDE; RUTOSIDE; TICLOPIDINE;

ADULT; AGRANULOCYTOSIS; ARTICLE; CHEMICALLY INDUCED DISORDER; CHILD; COMPARATIVE STUDY; HUMAN; ORAL DRUG ADMINISTRATION; POLAND; RETROSPECTIVE STUDY; SAFETY; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG USE; EPIDEMIOLOGY; FEMALE; HEMATOLOGY; INCIDENCE; MALE; MEDICAL RECORD; TIME;

ADMINISTRATION, ORAL; ADULT; AGRANULOCYTOSIS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; DIPYRONE; HUMANS; POLAND; RETROSPECTIVE STUDIES; SAFETY;

EID: 0036755112     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000203000504     Document Type: Article

References (20)

1. The International Agranulocytosis and Aplastic Anemia Study: Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. JAMA 1986; 256: 1749-1757.
2. Kaufman DW, Kelly JP, Levy M, Shapiro S (eds): The Drug Etiology of Agranulocytosis and Aplastic Anemia. New York: Oxford University Press, 1991; pp186-203.
3. Shapiro S, Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Thamprasit T, et al: Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group. Am J Trop Med Hyg 1999; 60: 573-577.
4. Heimpel H: Drug induced agranulocytosis. Med Toxicol Adverse Drug Exp 1988; 3: 449-462.
5. Kaufman DW, Kelly JP, Levy M: The Drug Etiology of Agranulocytosis and Aplastic Anaemia. Monographs in Epidemiology and Biostatistics 1991, volume 18. New York: Oxford University Press, pp5-9, 102-105, 296-304.
6. Coleman MD: Dapsone - mediated agranulo-cytosis: risks, possible mechanism and prevention. Toxicology 2001; 162: 53-60.
7. Hartl PW: Drug induced agranulocytosis. Med Toxicol Adverse Drug Exp 1988; 3: 449-462.
8. Brogden RN: Pyrazolone derivatives. Drugs 1986; 32 (Suppl 4): 60-70.
9. Arellano F, Sacristan JA: Metamizole: reassessment of its therapeutic role. Eur J Clin Pharmacol 1990; 38: 617-619.
10. Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR: An algorithm for the operational assessment of adverse drug reactions: background, description and instruction for use. J Am Med Assoc 1979; 242: 623-632.
11. Andrade SE, Martinez C, Walker AM: Comparative safety evaluation of non-narcotic analgesics. J Clin Epidemiol 1998; 51: 1357-1365.
12. Levy M: Adverse reactions to over-the counter analgesics: an epidemiological evaluation. Agents Actions Suppl 1988: 25: 21-31.
13. ICH Harmonised Tripartile Guideline: International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Data elements for transmission of individual case safety reports. Recommended for adoption at step 4 of the ICH process on 17 July 1977 by the ICH Steering Committee. Available at www.ich.org/ (accessed 2 September 2002).
14. Bottiger LE, Westerholm B: Drug induced blood dyscrasias in Sweden. BMJ 1973; 3: 339-343.
15. Shapiro S: Dipyrone hearing by the German Drug Authority. Lancet 1984; 1: 451-452.
16. Kaufman DW, Kelly JP, Jurgelon JM, Anderson T, Issaragrisil S, Wilholm B-E, et al: Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur J Haematol 1996; 57 (Suppl): 23-30.
17. Martinez C, Rietbrock S: Adverse public health impact of non-opiods: a meta analysis (abstract). Pharmacoepidemiol Drug Saf 1997; 6 (Suppl 2): S115.
18. Levy M: Unwanted drug effects of antipyretic analgesics: epidmiological data. In: New Pharmacoepidemiological Data in Analgesics Research (K Brune, ed). Bassel, Boston, Berlin: Birhäuser Verlag, 1990; pp39-47.
19. Consolidated list of products whose consumption and or sale have been banned, withdrawn, sevely restricted or not approved by Governments. Department of Policy Co-ordination and Sustainable Development. United Nations Publications Fifth Issue, 1994.
20. EEA National Regulatory Authorities: EU/EEA Rapid Alert, 28 April 1998.